John Oliver, a quality assurance specialist at SPS, presents a summary of the resources published by SPS between 6th and 12th September.
To easily find a list of newly published pages go to sps.nhs.uk, select ‘search’, click in the search bar, and press enter.
Quick links to highlighted resources:
Ensuring time critical use of rasburicase
Timely use of rasburicase for treatment of tumour lysis syndrome is essential. Mitigation strategies can minimise harm associated with delayed therapy.
https://www.sps.nhs.uk/articles/ensuring-time-critical-use-of-rasburicase/
Preparing to use denosumab 60mg biosimilar
Biosimilars of denosumab 60mg (Prolia) are expected soon. We offer general information and implementation advice.
https://www.sps.nhs.uk/articles/preparing-to-use-denosumab-60mg-biosimilar-for-osteoporosis/
Understanding biosimilar and generic market entry – explainer video
New medicines have several protections against competition. Other factors influence availability of biosimilars or generics after loss of exclusivity.
https://www.sps.nhs.uk/articles/understanding-biosimilar-and-generic-market-entry/
SPS Vacancies:
Senior Specialist Pharmacist Medicines Advice & Medicines Use and Safety (closing date 24 September)
https://www.jobs.nhs.uk/candidate/jobadvert/C9287-25-1466?keyword=pharmacist&location=Liverpool&distance=5&language=en&page=2
Senior Specialist Pharmacist, Medicines Use and Safety (closing date 24 September)
https://www.jobs.nhs.uk/candidate/jobadvert/C9287-25-1470
Next events – forthcoming webinars and conferences
https://www.sps.nhs.uk/home/events/next-events/
Podcast description:
NHS Specialist Pharmacy Service serves healthcare professionals across the NHS who are involved in all aspects of buying, making and using medicines. Our motto is 'do once and share'.
